Patient Engagement Solutions Market by Component (Hardware, Software & Services), Delivery Mode (On-premise, Web, & Cloud) & by End-user (Payer, Provider, Patients,& Others) - Trends & Global Forecasts to 2019

The healthcare industry is undergoing a fundamental transformation globally as it shifts from a volume-based to a value-based one. Growing demand from consumers for improved healthcare quality and greater value are forcing healthcare providers and payers to deliver optimized outcomes. In addition, governments across the globe are working toward reducing healthcare costs, which increases the burden on payers and providers to meet government as well as consumer expectations, thereby compelling them to move towards patient engagement solutions.
The global patient engagement solutions market is estimated to grow at a CAGR of 20% from 2014 to 2019, to reach $13.7 billion by 2019 from $5.5 billion in 2014.Over the years, the traditional approaches to patient care, quality assurance, and cost management have been inefficient. Therefore patient engagement solutions will be among the priorities on the investment list of healthcare organizations for improving quality outcomes and cost management. Based on the mode of delivery, web-based solutions accounted for the largest segment of the patient engagement solutions market in 2014. However, cloud-based solutions are the fastest-growing delivery modes.
Based on end users, the providers segment accounted for the largest share. However, the providers and payers segments are expected to grow at a rapid rate in the end-user market.
Based on applications, health management accounted for the largest share of the patient engagement solutions market in 2014. Chronic disease contributed to the largest share of the market, by therapeutic area and it is expected to grow at a rapid rate.

Based on geography, North America contributed to the largest share of the market. The large share of this region can be attributed to factors such as rising healthcare costs and demand for quality care, legislative reforms, rising aging and chronically ill population, and government support for patient engagement.

The patient engagement solutions market is highly fragmented with many small and large players. Companies in this market focus on growth strategies such as client acquisitions; agreements, partnerships, collaborations; new product launches; expansions; acquisitions; marketing and promotion; and others (funding, grant, product enhancement) to increase their customer base.

The major players in the global patient engagement solutions market include McKesson Corporation (U.S.), Medecision, Inc. (U.S.), Allscripts, Inc. (U.S.), Phytel Inc. (U.S.), Cerner Corporation (U.S.), Orion Health (New Zealand), Aetna, Inc. (U.S.), Athenahealth, Inc. (U.S.), Emmi Solutions LLC (U.S.), and GetWellNetwork, Inc. (U.S.).
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on product portfolio and services offered by the ten major players in the patient engagement solutions market. The report analyzes patient engagement solutions across geographies

‧ Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the patient engagement solutions market

‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the patient engagement solutions market across geographies

‧ Market Diversification: Extensive information about new products and services, untapped geographies, recent developments, and investments in the patient engagement solutions market

‧ Competitive Assessment: In-depth assessment of strategies, products, and services of leading players in the patient engagement solutions market

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKETS COVERED 18
1.3 STAKEHOLDERS 20
1.4 MARKET SCOPE 20
2 RESEARCH METHODOLOGY 21
2.1 MARKET SIZE ESTIMATION 21
2.1.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 21
2.1.1.1 Secondary Research 21
2.1.2 KEY DATA FROM SECONDARY SOURCES 22
2.1.2.1 Primary Research 23
2.1.3 KEY DATA FROM PRIMARY SOURCES 24
2.1.4 KEY INSIGHTS FROM PRIMARY SOURCES 24
2.1.4.1 Key Industry Insights 25
2.1.5 MARKET SIZE ESTIMATION METHODOLOGY 25
2.1.6 MARKET FORECAST METHODOLOGY 28
2.1.7 MARKET DATA VALIDATION AND DATA TRIANGULATION 28
2.1.8 ASSUMPTIONS 29
2.1.9 LIMITATIONS 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 33
4.1 ATTRACTIVE OPPORTUNITIES IN PATIENT ENGAGEMENT SOLUTIONS MARKET 33
4.3 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA 34
4.4 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER AND GEOGRAPHY 35
4.6 CAGR% (2014–2019) ACROSS GEOGRAPHIES 36
5 MARKET DYNAMICS 37
5.1 DRIVERS 38
5.1.1 IMPLEMENTATION OF ACT 38
5.1.2 RISE IN NUMBER OF ACCOUNTABLE CARE ORGANIZATIONS 38
5.1.3 FEDERAL MANDATE ENCOURAGES USE OF PATIENT ENGAGEMENT SOLUTIONS AMONG STAKEHOLDERS 39
5.1.4 RISE IN AGING POPULATION AND INCIDENCES OF CHRONIC DISEASES 39
5.1.5 INCENTIVES BY FEDERAL GOVERNMENT 40
5.1.6 HIGH RETURN ON INVESTMENT 42
5.1.7 HIGH INVESTMENTS BY PAYERS AND PROVIDERS 42
5.1.8 ADVANCED IT AND BIG DATA CAPABILITIES 43
5.1.9 INCREASING AWARENESS OF MOBILE HEALTH (M-HEALTH) 43
5.2 RESTRAINTS 43
5.2.1 NECESSITY OF CHANGE IN POLICIES AS WELL AS MIND-SET OF PROVIDERS 43
5.2.2 REQUIREMENT OF INFRASTRUCTURAL INVESTMENTS 44
5.2.3 LACK OF CONFIDENCE IN PATIENT ENGAGEMENT SOLUTIONS 44
5.2.4 FRAGMENTED END-USER MARKET 45
5.2.5 PROTECTION OF PATIENT INFORMATION 45
5.2.6 LACK OF HEALTH LITERACY 46
5.2.7 POOR ACCESS TO HEALTHCARE 46
5.3 OPPORTUNITIES 46
5.3.1 JAPAN & AUSTRALIA OFFER HUGE MARKET POTENTIAL 46
5.3.2 GROWING MEDICAL TOURISM 46
5.3.3 CLOUD-BASED MODELS 47
6 INDUSTRY TRENDS 48
6.1 FORCE-FIELD ANALYSIS 48
6.1.1 DRIVING FORCES 48
6.1.1.1 Awareness amongst patients about patient engagement solutions (PES) 48
6.1.1.2 Benefits to patients/patient empowerment 48
6.1.1.3 Ease of use 49
6.1.2 RESTRAINING FORCES 49
6.1.2.1 Requirement of healthcare information technology (HCIT) infrastructure 49
6.1.2.2 Reluctance of patients 49
6.1.2.3 Health information safety concerns 49
6.1.3 FORCE FIELD ANALYSIS 50
6.2 END-USER MARKET POTENTIAL ANALYSIS 52
6.3 PATIENT ENGAGEMENT MARKET: EMPIRICAL ASSESSMENT OF GROWTH STRATEGIES 53
6.3.1 ROUTE TO STRATEGIC GROWTH: ORGANIC AND INORGANIC GROWTH STRATEGIES 53
6.3.2 ORGANIC GROWTH STRATEGIES 54
6.3.3 INORGANIC GROWTH STRATEGIES 56
7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT 58
7.1 INTRODUCTION 59
7.2 HARDWARE 60
7.3 SOFTWARE 61
7.3.1 STANDALONE SOLUTIONS 62
7.3.2 INTEGRATED SOLUTIONS 63
7.4 SERVICES 64
7.4.1 CONSULTING SERVICES 65
7.4.2 IMPLEMENTATION SERVICES 65
7.4.3 TRAINING & EDUCATION SERVICES 65
7.4.4 OTHER SERVICES 65
7.4.4.1 Post-Sale & Maintenance Services 65
7.4.4.2 Advertising Services 65
7.4.4.3 Enrollment Services 66
8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY MODE OF DELIVERY 67
8.1 INTRODUCTION 68
8.2 WEB–BASED DELIVERY 70
8.3 ON–PREMISE 71
8.4 CLOUD-BASED 72
9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER 73
9.1 INTRODUCTION 74
9.2 PROVIDERS 75
9.3 PAYERS 76
9.4 PATIENTS 77
9.5 OTHERS 78
10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION 79
10.1 INTRODUCTION 80
10.2 HEALTH MANAGEMENT 82
10.3 SOCIAL AND BEHAVIORAL MANAGEMENT 83
10.4 HOME HEALTH MANAGEMENT 84
10.5 FINANCIAL HEALTH MANAGEMENT 85
11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA 86
11.1 INTRODUCTION 87
11.2 CHRONIC DISEASES 88
11.2.1 DIABETES 89
11.2.2 CARDIOVASCULAR DISEASE 90
11.2.3 OBESITY 91
11.2.4 OTHER CHRONIC DISEASES 92
11.3 WOMEN’S HEALTH 92
11.4 FITNESS 93
11.5 OTHER THERAPEUTIC AREAS 94
12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY GEOGRAPHY 95
12.1 INTRODUCTION 96
12.2 U.S. 102
12.2.1 PATIENT ENGAGEMENT SOLUTIONS A VITAL TOOL IN CURBING HEALTHCARE COSTS IN THE U.S. 102
12.2.2 REGULATORY MANDATES BY ACA STIMULATING THE U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET 102
12.2.3 AGING POPULATION IN THE U.S. TO AID THE GROWTH OF THE PES MARKET 103
12.2.4 RISING PREVALENCE OF CHRONIC DISEASES TO PROPEL MARKET 103
12.3 CANADA 107
12.4 EUROPE 111
12.4.1 RISE IN HEALTHCARE COSTS, AGING POPULATION LIKELY TO STIMULATE EUROPEAN MARKET 111
12.4.2 EHRS LAYING THE FOUNDATION FOR ADOPTION OF PATIENT ENGAGEMENT SOLUTIONS 111
12.4.3 GROWTH OF HCIT MARKET, CONSOLIDATION OF HEALTHCARE PROVIDERS IN EUROPE BODES WELL FOR PES MARKET 111
12.4.4 CONFERENCES TO CREATE AWARENESS ABOUT PATIENT ENGAGEMENT SOLUTIONS 112
12.5 ASIA 116
12.5.1 GROWTH IN MEDICAL TOURISM SET TO PROPEL ASIAN PATIENT ENGAGEMENT SOLUTIONS MARKET 116
12.5.2 PATIENT ENGAGEMENT SOLUTIONS A WAY TO CONTROL RISING HEALTHCARE EXPENDITURE IN INDIA 116
12.5.3 INCREASE IN INVESTMENT BY JAPAN IN HEALTHCARE ICT SECTOR TO STIMULATE THE MARKET 116
12.6 REST OF THE WORLD 121
12.6.1 HEALTHCARE INVESTMENTS IN THE MIDDLE EAST BOOSTING PATIENT ENGAGEMENT SOLUTIONS MARKET 121
12.6.2 GROWTH OF HCIT MARKET IN LATIN AMERICA LIKELY TO PROPEL PATIENT ENGAGEMENT SOLUTIONS MARKET 121
12.6.3 AUSTRALIA IMPLEMENTING A NUMBER OF HCIT PROGRAMS 121
13 COMPETITIVE LANDSCAPE 126
13.1 INTRODUCTION 126
13.2 CLIENT ACQUISITIONS 128
13.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 130
13.4 NEW PRODUCT LAUNCHES 132
13.5 EXPANSIONS 134
13.6 ACQUISITIONS 136
13.7 MARKETING AND PROMOTIONAL ACTIVITIES 137
13.8 OTHERS 140
14 COMPANY PROFILES 142
14.1 AETNA, INC. 142
14.2 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. 148
14.3 ATHENAHEALTH, INC. 152
14.4 CERNER CORPORATION 158
14.5 EMMI SOLUTIONS LLC 161
14.6 GETWELLNETWORK, INC. 164
14.7 MCKESSON CORPORATION 168
14.8 MEDECISION, INC. 172
14.9 ORION HEALTH 175
14.10 PHYTEL, INC. 178

*Details on Business Overview, Financial Overview, Services Offered, Key Strategy, and Recent Developments might not be captured in case of unlisted companies.

15 APPENDIX 183
15.1 DISCUSSION GUIDE 183
15.2 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 186
15.3 AVAILABLE CUSTOMIZATIONS 188
15.4 RELATED REPORTS 188